Vitamin Blue, Inc. (VTMB)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Aug 10, 2026
Vitamin Blue Statistics
Total Valuation
Vitamin Blue has a market cap or net worth of 1,653.
| Market Cap | 1,653 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Vitamin Blue has 1.65 billion shares outstanding.
| Current Share Class | 1.65B |
| Shares Outstanding | 1.65B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +11.51% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.22 |
| Interest Coverage | -0.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -140.42% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 12.78% |
| Weighted Average Cost of Capital (WACC) | 70.56% |
| Revenue Per Employee | 73,107 |
| Profits Per Employee | -640,509 |
| Employee Count | 3 |
| Asset Turnover | 2.89 |
| Inventory Turnover | 7.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 66.21 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 41.10 |
| Average Volume (20 Days) | 818,538 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitamin Blue had revenue of 146,214 and -1.28 million in losses. Loss per share was -0.00.
| Revenue | 146,214 |
| Gross Profit | 60,235 |
| Operating Income | -113,749 |
| Pretax Income | -1.28M |
| Net Income | -1.28M |
| EBITDA | -112,373 |
| EBIT | -113,749 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 2,522 in cash and 307,365 in debt, with a net cash position of -304,843 or -0.00 per share.
| Cash & Cash Equivalents | 2,522 |
| Total Debt | 307,365 |
| Net Cash | -304,843 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -890,181 |
| Book Value Per Share | -0.00 |
| Working Capital | -900,772 |
Cash Flow
| Operating Cash Flow | -72,825 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1,376 |
| Net Borrowing | 75,000 |
| Free Cash Flow | -72,825 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 41.20% |
| Operating Margin | -77.80% |
| Pretax Margin | -876.13% |
| Profit Margin | n/a |
| EBITDA Margin | -76.86% |
| EBIT Margin | -77.80% |
| FCF Margin | n/a |
Dividends & Yields
Vitamin Blue does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.25% |
| Shareholder Yield | -16.25% |
| Earnings Yield | -77,496.55% |
| FCF Yield | -4,405.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vitamin Blue has an Altman Z-Score of -87.85 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -87.85 |
| Piotroski F-Score | 2 |